01 4Belmore Neidrauer LLP
01 22534024
02 22671357
01 4CANAGLIFLOZIN
01 4TABLET
01 22024-07-30
02 22027-12-03
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Brand Name : INVOKANA
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Brand Name : INVOKANA
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Brand Name : INVOKANA
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 300 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Brand Name : INVOKANA
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 300 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
LOOKING FOR A SUPPLIER?
